nodes	percent_of_prediction	percent_of_DWPC	metapath
Rifabutin—CYP3A4—Methylprednisolone—psoriatic arthritis	0.121	0.248	CbGbCtD
Rifabutin—CYP3A4—Triamcinolone—psoriatic arthritis	0.0918	0.188	CbGbCtD
Rifabutin—CYP3A4—Betamethasone—psoriatic arthritis	0.0787	0.161	CbGbCtD
Rifabutin—CYP3A4—Prednisolone—psoriatic arthritis	0.0777	0.159	CbGbCtD
Rifabutin—CYP3A4—Prednisone—psoriatic arthritis	0.0734	0.15	CbGbCtD
Rifabutin—Burkitt's lymphoma—Methotrexate—psoriatic arthritis	0.0524	0.135	CcSEcCtD
Rifabutin—CYP3A4—Dexamethasone—psoriatic arthritis	0.0458	0.0937	CbGbCtD
Rifabutin—HSP90AA1—NOD pathway—MEFV—psoriatic arthritis	0.0171	0.138	CbGpPWpGaD
Rifabutin—Hepatic enzyme increased—Auranofin—psoriatic arthritis	0.0137	0.0353	CcSEcCtD
Rifabutin—HSP90B1—IL6-mediated signaling events—CRP—psoriatic arthritis	0.0105	0.0849	CbGpPWpGaD
Rifabutin—Eosinophilia—Auranofin—psoriatic arthritis	0.00804	0.0208	CcSEcCtD
Rifabutin—HSP90AA1—Regulation of Androgen receptor activity—REL—psoriatic arthritis	0.00775	0.0626	CbGpPWpGaD
Rifabutin—Pancytopenia—Auranofin—psoriatic arthritis	0.00772	0.0199	CcSEcCtD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—IL13—psoriatic arthritis	0.00766	0.0618	CbGpPWpGaD
Rifabutin—Neutropenia—Auranofin—psoriatic arthritis	0.0076	0.0196	CcSEcCtD
Rifabutin—Jaundice—Auranofin—psoriatic arthritis	0.00706	0.0182	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.0068	0.0548	CbGpPWpGaD
Rifabutin—Agranulocytosis—Auranofin—psoriatic arthritis	0.00676	0.0174	CcSEcCtD
Rifabutin—HSP90AA1—NOD pathway—NOD2—psoriatic arthritis	0.00644	0.052	CbGpPWpGaD
Rifabutin—HSP90B1—Toll-Like Receptors Cascades—NOD2—psoriatic arthritis	0.00615	0.0496	CbGpPWpGaD
Rifabutin—Eye disorder—Auranofin—psoriatic arthritis	0.00608	0.0157	CcSEcCtD
Rifabutin—Lymphopenia—Prednisone—psoriatic arthritis	0.00586	0.0151	CcSEcCtD
Rifabutin—Flatulence—Auranofin—psoriatic arthritis	0.00558	0.0144	CcSEcCtD
Rifabutin—Dysgeusia—Auranofin—psoriatic arthritis	0.00554	0.0143	CcSEcCtD
Rifabutin—Bacterial infection—Methotrexate—psoriatic arthritis	0.00543	0.014	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—MEFV—psoriatic arthritis	0.00529	0.0427	CbGpPWpGaD
Rifabutin—Anaemia—Auranofin—psoriatic arthritis	0.00523	0.0135	CcSEcCtD
Rifabutin—Leukopenia—Auranofin—psoriatic arthritis	0.00507	0.0131	CcSEcCtD
Rifabutin—HSP90AA1—Glucocorticoid receptor regulatory network—IL13—psoriatic arthritis	0.005	0.0404	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—REL—psoriatic arthritis	0.00499	0.0403	CbGpPWpGaD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—TNFRSF1B—psoriatic arthritis	0.00471	0.038	CbGpPWpGaD
Rifabutin—Thrombocytopenia—Auranofin—psoriatic arthritis	0.00452	0.0117	CcSEcCtD
Rifabutin—Anorexia—Auranofin—psoriatic arthritis	0.0044	0.0114	CcSEcCtD
Rifabutin—Dyspepsia—Auranofin—psoriatic arthritis	0.00407	0.0105	CcSEcCtD
Rifabutin—Decreased appetite—Auranofin—psoriatic arthritis	0.00402	0.0104	CcSEcCtD
Rifabutin—Aphasia—Methotrexate—psoriatic arthritis	0.00387	0.00998	CcSEcCtD
Rifabutin—Gastrointestinal pain—Auranofin—psoriatic arthritis	0.00378	0.00975	CcSEcCtD
Rifabutin—Abdominal pain—Auranofin—psoriatic arthritis	0.00365	0.00942	CcSEcCtD
Rifabutin—HSP90AA1—EBV LMP1 signaling—TNF—psoriatic arthritis	0.00329	0.0266	CbGpPWpGaD
Rifabutin—Pruritus—Auranofin—psoriatic arthritis	0.00327	0.00843	CcSEcCtD
Rifabutin—Blood alkaline phosphatase increased—Methylprednisolone—psoriatic arthritis	0.00316	0.00816	CcSEcCtD
Rifabutin—Diarrhoea—Auranofin—psoriatic arthritis	0.00316	0.00816	CcSEcCtD
Rifabutin—HSP90B1—Immune System—MEFV—psoriatic arthritis	0.00308	0.0249	CbGpPWpGaD
Rifabutin—Vomiting—Auranofin—psoriatic arthritis	0.00294	0.00758	CcSEcCtD
Rifabutin—Rash—Auranofin—psoriatic arthritis	0.00291	0.00752	CcSEcCtD
Rifabutin—Dermatitis—Auranofin—psoriatic arthritis	0.00291	0.00751	CcSEcCtD
Rifabutin—Skin discolouration—Methotrexate—psoriatic arthritis	0.00278	0.00716	CcSEcCtD
Rifabutin—Nausea—Auranofin—psoriatic arthritis	0.00274	0.00708	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—HLA-C—psoriatic arthritis	0.00271	0.0218	CbGpPWpGaD
Rifabutin—Hepatic enzyme increased—Methotrexate—psoriatic arthritis	0.00265	0.00684	CcSEcCtD
Rifabutin—Alanine aminotransferase increased—Methylprednisolone—psoriatic arthritis	0.00243	0.00626	CcSEcCtD
Rifabutin—Bronchospasm—Methylprednisolone—psoriatic arthritis	0.00234	0.00603	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—MEFV—psoriatic arthritis	0.00206	0.0167	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—NOD2—psoriatic arthritis	0.00199	0.0161	CbGpPWpGaD
Rifabutin—HSP90B1—Metabolism of proteins—ACE—psoriatic arthritis	0.00195	0.0157	CbGpPWpGaD
Rifabutin—Alanine aminotransferase increased—Prednisone—psoriatic arthritis	0.00192	0.00496	CcSEcCtD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	0.00189	0.0153	CbGpPWpGaD
Rifabutin—HSP90AA1—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.00189	0.0153	CbGpPWpGaD
Rifabutin—Connective tissue disorder—Methylprednisolone—psoriatic arthritis	0.00187	0.00482	CcSEcCtD
Rifabutin—HSP90B1—SIDS Susceptibility Pathways—TNF—psoriatic arthritis	0.00182	0.0147	CbGpPWpGaD
Rifabutin—Eye disorder—Methylprednisolone—psoriatic arthritis	0.00178	0.00459	CcSEcCtD
Rifabutin—Neutropenia—Prednisone—psoriatic arthritis	0.00176	0.00454	CcSEcCtD
Rifabutin—Immune system disorder—Methylprednisolone—psoriatic arthritis	0.00172	0.00443	CcSEcCtD
Rifabutin—HSP90B1—Immune System—REL—psoriatic arthritis	0.00171	0.0138	CbGpPWpGaD
Rifabutin—Dysgeusia—Triamcinolone—psoriatic arthritis	0.00163	0.00419	CcSEcCtD
Rifabutin—Eye disorder—Dexamethasone—psoriatic arthritis	0.00162	0.00417	CcSEcCtD
Rifabutin—Eye disorder—Betamethasone—psoriatic arthritis	0.00162	0.00417	CcSEcCtD
Rifabutin—HSP90B1—Innate Immune System—HLA-B—psoriatic arthritis	0.0016	0.0129	CbGpPWpGaD
Rifabutin—HSP90B1—Immune System—HLA-C—psoriatic arthritis	0.00158	0.0127	CbGpPWpGaD
Rifabutin—Convulsion—Prednisolone—psoriatic arthritis	0.00156	0.00404	CcSEcCtD
Rifabutin—Eosinophilia—Methotrexate—psoriatic arthritis	0.00156	0.00402	CcSEcCtD
Rifabutin—Pancytopenia—Methotrexate—psoriatic arthritis	0.00149	0.00386	CcSEcCtD
Rifabutin—Connective tissue disorder—Prednisone—psoriatic arthritis	0.00148	0.00382	CcSEcCtD
Rifabutin—Neutropenia—Methotrexate—psoriatic arthritis	0.00147	0.0038	CcSEcCtD
Rifabutin—Shock—Prednisolone—psoriatic arthritis	0.00145	0.00374	CcSEcCtD
Rifabutin—Convulsion—Triamcinolone—psoriatic arthritis	0.00144	0.00371	CcSEcCtD
Rifabutin—Convulsion—Methylprednisolone—psoriatic arthritis	0.00144	0.0037	CcSEcCtD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL12B—psoriatic arthritis	0.00143	0.0115	CbGpPWpGaD
Rifabutin—HSP90B1—Innate Immune System—CRP—psoriatic arthritis	0.00141	0.0114	CbGpPWpGaD
Rifabutin—Myalgia—Triamcinolone—psoriatic arthritis	0.00141	0.00365	CcSEcCtD
Rifabutin—Arthralgia—Methylprednisolone—psoriatic arthritis	0.00141	0.00364	CcSEcCtD
Rifabutin—Myalgia—Methylprednisolone—psoriatic arthritis	0.00141	0.00364	CcSEcCtD
Rifabutin—Eye disorder—Prednisone—psoriatic arthritis	0.00141	0.00363	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—psoriatic arthritis	0.0014	0.00361	CcSEcCtD
Rifabutin—Confusional state—Methylprednisolone—psoriatic arthritis	0.00136	0.00352	CcSEcCtD
Rifabutin—Immune system disorder—Prednisone—psoriatic arthritis	0.00136	0.00351	CcSEcCtD
Rifabutin—Shock—Triamcinolone—psoriatic arthritis	0.00133	0.00344	CcSEcCtD
Rifabutin—Insomnia—Prednisolone—psoriatic arthritis	0.00133	0.00344	CcSEcCtD
Rifabutin—Shock—Methylprednisolone—psoriatic arthritis	0.00133	0.00343	CcSEcCtD
Rifabutin—Hepatobiliary disease—Methotrexate—psoriatic arthritis	0.00133	0.00342	CcSEcCtD
Rifabutin—Paraesthesia—Prednisolone—psoriatic arthritis	0.00132	0.00341	CcSEcCtD
Rifabutin—Skin disorder—Methylprednisolone—psoriatic arthritis	0.00131	0.00339	CcSEcCtD
Rifabutin—Agranulocytosis—Methotrexate—psoriatic arthritis	0.00131	0.00338	CcSEcCtD
Rifabutin—Convulsion—Betamethasone—psoriatic arthritis	0.0013	0.00337	CcSEcCtD
Rifabutin—Convulsion—Dexamethasone—psoriatic arthritis	0.0013	0.00337	CcSEcCtD
Rifabutin—Myalgia—Dexamethasone—psoriatic arthritis	0.00128	0.00331	CcSEcCtD
Rifabutin—Myalgia—Betamethasone—psoriatic arthritis	0.00128	0.00331	CcSEcCtD
Rifabutin—Pain—Prednisolone—psoriatic arthritis	0.00126	0.00325	CcSEcCtD
Rifabutin—Hepatitis—Methotrexate—psoriatic arthritis	0.00126	0.00325	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Triamcinolone—psoriatic arthritis	0.00123	0.00318	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Methylprednisolone—psoriatic arthritis	0.00123	0.00318	CcSEcCtD
Rifabutin—Insomnia—Triamcinolone—psoriatic arthritis	0.00123	0.00316	CcSEcCtD
Rifabutin—Insomnia—Methylprednisolone—psoriatic arthritis	0.00122	0.00315	CcSEcCtD
Rifabutin—Paraesthesia—Triamcinolone—psoriatic arthritis	0.00122	0.00314	CcSEcCtD
Rifabutin—Feeling abnormal—Prednisolone—psoriatic arthritis	0.00121	0.00313	CcSEcCtD
Rifabutin—Paraesthesia—Methylprednisolone—psoriatic arthritis	0.00121	0.00313	CcSEcCtD
Rifabutin—Anaemia—Prednisone—psoriatic arthritis	0.00121	0.00313	CcSEcCtD
Rifabutin—Shock—Dexamethasone—psoriatic arthritis	0.00121	0.00312	CcSEcCtD
Rifabutin—Shock—Betamethasone—psoriatic arthritis	0.00121	0.00312	CcSEcCtD
Rifabutin—Dyspnoea—Triamcinolone—psoriatic arthritis	0.00121	0.00312	CcSEcCtD
Rifabutin—Thrombocytopenia—Betamethasone—psoriatic arthritis	0.0012	0.00311	CcSEcCtD
Rifabutin—Thrombocytopenia—Dexamethasone—psoriatic arthritis	0.0012	0.00311	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—MEFV—psoriatic arthritis	0.0012	0.0097	CbGpPWpGaD
Rifabutin—Dyspepsia—Triamcinolone—psoriatic arthritis	0.00119	0.00308	CcSEcCtD
Rifabutin—Dyspepsia—Methylprednisolone—psoriatic arthritis	0.00119	0.00307	CcSEcCtD
Rifabutin—Eye disorder—Methotrexate—psoriatic arthritis	0.00118	0.00304	CcSEcCtD
Rifabutin—Anorexia—Betamethasone—psoriatic arthritis	0.00117	0.00302	CcSEcCtD
Rifabutin—Anorexia—Dexamethasone—psoriatic arthritis	0.00117	0.00302	CcSEcCtD
Rifabutin—HSP90B1—Immune System—NOD2—psoriatic arthritis	0.00116	0.00936	CbGpPWpGaD
Rifabutin—Pain—Triamcinolone—psoriatic arthritis	0.00116	0.00299	CcSEcCtD
Rifabutin—Immune system disorder—Methotrexate—psoriatic arthritis	0.00114	0.00293	CcSEcCtD
Rifabutin—Convulsion—Prednisone—psoriatic arthritis	0.00114	0.00293	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Betamethasone—psoriatic arthritis	0.00112	0.00289	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Dexamethasone—psoriatic arthritis	0.00112	0.00289	CcSEcCtD
Rifabutin—Arthralgia—Prednisone—psoriatic arthritis	0.00112	0.00288	CcSEcCtD
Rifabutin—Myalgia—Prednisone—psoriatic arthritis	0.00112	0.00288	CcSEcCtD
Rifabutin—Feeling abnormal—Triamcinolone—psoriatic arthritis	0.00112	0.00288	CcSEcCtD
Rifabutin—Feeling abnormal—Methylprednisolone—psoriatic arthritis	0.00111	0.00287	CcSEcCtD
Rifabutin—Insomnia—Betamethasone—psoriatic arthritis	0.00111	0.00287	CcSEcCtD
Rifabutin—Insomnia—Dexamethasone—psoriatic arthritis	0.00111	0.00287	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—psoriatic arthritis	0.00111	0.00286	CcSEcCtD
Rifabutin—Gastrointestinal pain—Methylprednisolone—psoriatic arthritis	0.00111	0.00285	CcSEcCtD
Rifabutin—Paraesthesia—Betamethasone—psoriatic arthritis	0.0011	0.00285	CcSEcCtD
Rifabutin—Paraesthesia—Dexamethasone—psoriatic arthritis	0.0011	0.00285	CcSEcCtD
Rifabutin—HSP90AA1—TNF alpha Signaling Pathway—TNF—psoriatic arthritis	0.00109	0.00877	CbGpPWpGaD
Rifabutin—Hypersensitivity—Prednisolone—psoriatic arthritis	0.00109	0.0028	CcSEcCtD
Rifabutin—Dyspepsia—Betamethasone—psoriatic arthritis	0.00108	0.00279	CcSEcCtD
Rifabutin—Dyspepsia—Dexamethasone—psoriatic arthritis	0.00108	0.00279	CcSEcCtD
Rifabutin—Dysgeusia—Methotrexate—psoriatic arthritis	0.00107	0.00277	CcSEcCtD
Rifabutin—Body temperature increased—Triamcinolone—psoriatic arthritis	0.00107	0.00276	CcSEcCtD
Rifabutin—Abdominal pain—Methylprednisolone—psoriatic arthritis	0.00107	0.00276	CcSEcCtD
Rifabutin—Decreased appetite—Dexamethasone—psoriatic arthritis	0.00107	0.00276	CcSEcCtD
Rifabutin—Decreased appetite—Betamethasone—psoriatic arthritis	0.00107	0.00276	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Betamethasone—psoriatic arthritis	0.00106	0.00274	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Dexamethasone—psoriatic arthritis	0.00106	0.00274	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—HLA-C—psoriatic arthritis	0.00106	0.00853	CbGpPWpGaD
Rifabutin—Shock—Prednisone—psoriatic arthritis	0.00105	0.00272	CcSEcCtD
Rifabutin—Pain—Dexamethasone—psoriatic arthritis	0.00105	0.00271	CcSEcCtD
Rifabutin—Pain—Betamethasone—psoriatic arthritis	0.00105	0.00271	CcSEcCtD
Rifabutin—Skin disorder—Prednisone—psoriatic arthritis	0.00104	0.00268	CcSEcCtD
Rifabutin—Anorexia—Prednisone—psoriatic arthritis	0.00102	0.00263	CcSEcCtD
Rifabutin—Anaemia—Methotrexate—psoriatic arthritis	0.00101	0.00261	CcSEcCtD
Rifabutin—Feeling abnormal—Betamethasone—psoriatic arthritis	0.00101	0.00261	CcSEcCtD
Rifabutin—Feeling abnormal—Dexamethasone—psoriatic arthritis	0.00101	0.00261	CcSEcCtD
Rifabutin—Gastrointestinal pain—Dexamethasone—psoriatic arthritis	0.00101	0.00259	CcSEcCtD
Rifabutin—Gastrointestinal pain—Betamethasone—psoriatic arthritis	0.00101	0.00259	CcSEcCtD
Rifabutin—Hypersensitivity—Triamcinolone—psoriatic arthritis	0.000998	0.00258	CcSEcCtD
Rifabutin—Hypersensitivity—Methylprednisolone—psoriatic arthritis	0.000996	0.00257	CcSEcCtD
Rifabutin—Leukopenia—Methotrexate—psoriatic arthritis	0.000981	0.00253	CcSEcCtD
Rifabutin—Musculoskeletal discomfort—Prednisone—psoriatic arthritis	0.000975	0.00252	CcSEcCtD
Rifabutin—Asthenia—Triamcinolone—psoriatic arthritis	0.000972	0.00251	CcSEcCtD
Rifabutin—Body temperature increased—Dexamethasone—psoriatic arthritis	0.000972	0.00251	CcSEcCtD
Rifabutin—Body temperature increased—Betamethasone—psoriatic arthritis	0.000972	0.00251	CcSEcCtD
Rifabutin—Abdominal pain—Dexamethasone—psoriatic arthritis	0.000972	0.00251	CcSEcCtD
Rifabutin—Abdominal pain—Betamethasone—psoriatic arthritis	0.000972	0.00251	CcSEcCtD
Rifabutin—Asthenia—Methylprednisolone—psoriatic arthritis	0.00097	0.0025	CcSEcCtD
Rifabutin—Insomnia—Prednisone—psoriatic arthritis	0.000968	0.0025	CcSEcCtD
Rifabutin—Paraesthesia—Prednisone—psoriatic arthritis	0.000961	0.00248	CcSEcCtD
Rifabutin—Pruritus—Triamcinolone—psoriatic arthritis	0.000958	0.00247	CcSEcCtD
Rifabutin—Pruritus—Methylprednisolone—psoriatic arthritis	0.000956	0.00247	CcSEcCtD
Rifabutin—Convulsion—Methotrexate—psoriatic arthritis	0.00095	0.00245	CcSEcCtD
Rifabutin—Dyspepsia—Prednisone—psoriatic arthritis	0.000942	0.00243	CcSEcCtD
Rifabutin—Myalgia—Methotrexate—psoriatic arthritis	0.000933	0.00241	CcSEcCtD
Rifabutin—Arthralgia—Methotrexate—psoriatic arthritis	0.000933	0.00241	CcSEcCtD
Rifabutin—Chest pain—Methotrexate—psoriatic arthritis	0.000933	0.00241	CcSEcCtD
Rifabutin—HSP90B1—Immune System—HLA-B—psoriatic arthritis	0.000932	0.00752	CbGpPWpGaD
Rifabutin—Decreased appetite—Prednisone—psoriatic arthritis	0.000931	0.0024	CcSEcCtD
Rifabutin—Rash—Prednisolone—psoriatic arthritis	0.000929	0.0024	CcSEcCtD
Rifabutin—Dermatitis—Prednisolone—psoriatic arthritis	0.000928	0.00239	CcSEcCtD
Rifabutin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—psoriatic arthritis	0.000927	0.00239	CcSEcCtD
Rifabutin—Diarrhoea—Methylprednisolone—psoriatic arthritis	0.000925	0.00239	CcSEcCtD
Rifabutin—Headache—Prednisolone—psoriatic arthritis	0.000923	0.00238	CcSEcCtD
Rifabutin—Confusional state—Methotrexate—psoriatic arthritis	0.000902	0.00233	CcSEcCtD
Rifabutin—Feeling abnormal—Prednisone—psoriatic arthritis	0.000882	0.00228	CcSEcCtD
Rifabutin—Asthenia—Betamethasone—psoriatic arthritis	0.000882	0.00228	CcSEcCtD
Rifabutin—Asthenia—Dexamethasone—psoriatic arthritis	0.000882	0.00228	CcSEcCtD
Rifabutin—Thrombocytopenia—Methotrexate—psoriatic arthritis	0.000876	0.00226	CcSEcCtD
Rifabutin—Gastrointestinal pain—Prednisone—psoriatic arthritis	0.000875	0.00226	CcSEcCtD
Rifabutin—Nausea—Prednisolone—psoriatic arthritis	0.000875	0.00226	CcSEcCtD
Rifabutin—Pruritus—Betamethasone—psoriatic arthritis	0.00087	0.00224	CcSEcCtD
Rifabutin—Pruritus—Dexamethasone—psoriatic arthritis	0.00087	0.00224	CcSEcCtD
Rifabutin—Skin disorder—Methotrexate—psoriatic arthritis	0.000869	0.00224	CcSEcCtD
Rifabutin—Vomiting—Triamcinolone—psoriatic arthritis	0.000861	0.00222	CcSEcCtD
Rifabutin—Vomiting—Methylprednisolone—psoriatic arthritis	0.000859	0.00222	CcSEcCtD
Rifabutin—Rash—Triamcinolone—psoriatic arthritis	0.000854	0.0022	CcSEcCtD
Rifabutin—Dermatitis—Triamcinolone—psoriatic arthritis	0.000853	0.0022	CcSEcCtD
Rifabutin—Anorexia—Methotrexate—psoriatic arthritis	0.000853	0.0022	CcSEcCtD
Rifabutin—Rash—Methylprednisolone—psoriatic arthritis	0.000852	0.0022	CcSEcCtD
Rifabutin—Dermatitis—Methylprednisolone—psoriatic arthritis	0.000852	0.0022	CcSEcCtD
Rifabutin—Headache—Triamcinolone—psoriatic arthritis	0.000849	0.00219	CcSEcCtD
Rifabutin—Headache—Methylprednisolone—psoriatic arthritis	0.000847	0.00218	CcSEcCtD
Rifabutin—Abdominal pain—Prednisone—psoriatic arthritis	0.000846	0.00218	CcSEcCtD
Rifabutin—Body temperature increased—Prednisone—psoriatic arthritis	0.000846	0.00218	CcSEcCtD
Rifabutin—Diarrhoea—Betamethasone—psoriatic arthritis	0.000841	0.00217	CcSEcCtD
Rifabutin—Diarrhoea—Dexamethasone—psoriatic arthritis	0.000841	0.00217	CcSEcCtD
Rifabutin—HSP90B1—Immune System—CRP—psoriatic arthritis	0.000824	0.00665	CbGpPWpGaD
Rifabutin—Musculoskeletal discomfort—Methotrexate—psoriatic arthritis	0.000815	0.0021	CcSEcCtD
Rifabutin—Insomnia—Methotrexate—psoriatic arthritis	0.000809	0.00209	CcSEcCtD
Rifabutin—Nausea—Triamcinolone—psoriatic arthritis	0.000805	0.00208	CcSEcCtD
Rifabutin—Paraesthesia—Methotrexate—psoriatic arthritis	0.000803	0.00207	CcSEcCtD
Rifabutin—Nausea—Methylprednisolone—psoriatic arthritis	0.000803	0.00207	CcSEcCtD
Rifabutin—Dyspnoea—Methotrexate—psoriatic arthritis	0.000798	0.00206	CcSEcCtD
Rifabutin—HSP90B1—Immune System—HLA-DRB1—psoriatic arthritis	0.000789	0.00637	CbGpPWpGaD
Rifabutin—Hypersensitivity—Prednisone—psoriatic arthritis	0.000789	0.00204	CcSEcCtD
Rifabutin—Dyspepsia—Methotrexate—psoriatic arthritis	0.000788	0.00203	CcSEcCtD
Rifabutin—Vomiting—Betamethasone—psoriatic arthritis	0.000782	0.00202	CcSEcCtD
Rifabutin—Vomiting—Dexamethasone—psoriatic arthritis	0.000782	0.00202	CcSEcCtD
Rifabutin—Decreased appetite—Methotrexate—psoriatic arthritis	0.000778	0.00201	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—NOD2—psoriatic arthritis	0.000777	0.00627	CbGpPWpGaD
Rifabutin—Rash—Dexamethasone—psoriatic arthritis	0.000775	0.002	CcSEcCtD
Rifabutin—Rash—Betamethasone—psoriatic arthritis	0.000775	0.002	CcSEcCtD
Rifabutin—Dermatitis—Dexamethasone—psoriatic arthritis	0.000774	0.002	CcSEcCtD
Rifabutin—Dermatitis—Betamethasone—psoriatic arthritis	0.000774	0.002	CcSEcCtD
Rifabutin—Gastrointestinal disorder—Methotrexate—psoriatic arthritis	0.000772	0.00199	CcSEcCtD
Rifabutin—Headache—Betamethasone—psoriatic arthritis	0.00077	0.00199	CcSEcCtD
Rifabutin—Headache—Dexamethasone—psoriatic arthritis	0.00077	0.00199	CcSEcCtD
Rifabutin—Asthenia—Prednisone—psoriatic arthritis	0.000768	0.00198	CcSEcCtD
Rifabutin—Pain—Methotrexate—psoriatic arthritis	0.000765	0.00197	CcSEcCtD
Rifabutin—Pruritus—Prednisone—psoriatic arthritis	0.000757	0.00195	CcSEcCtD
Rifabutin—Feeling abnormal—Methotrexate—psoriatic arthritis	0.000737	0.0019	CcSEcCtD
Rifabutin—Diarrhoea—Prednisone—psoriatic arthritis	0.000732	0.00189	CcSEcCtD
Rifabutin—Gastrointestinal pain—Methotrexate—psoriatic arthritis	0.000732	0.00189	CcSEcCtD
Rifabutin—Nausea—Dexamethasone—psoriatic arthritis	0.00073	0.00188	CcSEcCtD
Rifabutin—Nausea—Betamethasone—psoriatic arthritis	0.00073	0.00188	CcSEcCtD
Rifabutin—Abdominal pain—Methotrexate—psoriatic arthritis	0.000707	0.00182	CcSEcCtD
Rifabutin—Body temperature increased—Methotrexate—psoriatic arthritis	0.000707	0.00182	CcSEcCtD
Rifabutin—Vomiting—Prednisone—psoriatic arthritis	0.000681	0.00176	CcSEcCtD
Rifabutin—Rash—Prednisone—psoriatic arthritis	0.000675	0.00174	CcSEcCtD
Rifabutin—Dermatitis—Prednisone—psoriatic arthritis	0.000674	0.00174	CcSEcCtD
Rifabutin—Headache—Prednisone—psoriatic arthritis	0.000671	0.00173	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—REL—psoriatic arthritis	0.000669	0.0054	CbGpPWpGaD
Rifabutin—Hypersensitivity—Methotrexate—psoriatic arthritis	0.000659	0.0017	CcSEcCtD
Rifabutin—Asthenia—Methotrexate—psoriatic arthritis	0.000642	0.00166	CcSEcCtD
Rifabutin—Nausea—Prednisone—psoriatic arthritis	0.000636	0.00164	CcSEcCtD
Rifabutin—Pruritus—Methotrexate—psoriatic arthritis	0.000633	0.00163	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—HLA-B—psoriatic arthritis	0.000625	0.00504	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HLA-C—psoriatic arthritis	0.000615	0.00497	CbGpPWpGaD
Rifabutin—Diarrhoea—Methotrexate—psoriatic arthritis	0.000612	0.00158	CcSEcCtD
Rifabutin—Vomiting—Methotrexate—psoriatic arthritis	0.000569	0.00147	CcSEcCtD
Rifabutin—Rash—Methotrexate—psoriatic arthritis	0.000564	0.00146	CcSEcCtD
Rifabutin—Dermatitis—Methotrexate—psoriatic arthritis	0.000564	0.00145	CcSEcCtD
Rifabutin—Headache—Methotrexate—psoriatic arthritis	0.00056	0.00145	CcSEcCtD
Rifabutin—HSP90AA1—Innate Immune System—CRP—psoriatic arthritis	0.000552	0.00446	CbGpPWpGaD
Rifabutin—Nausea—Methotrexate—psoriatic arthritis	0.000531	0.00137	CcSEcCtD
Rifabutin—HSP90AA1—Immune System—NOD2—psoriatic arthritis	0.000453	0.00365	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—psoriatic arthritis	0.000398	0.00321	CbGpPWpGaD
Rifabutin—CYP1A2—Aryl Hydrocarbon Receptor—TNF—psoriatic arthritis	0.000398	0.00321	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HLA-B—psoriatic arthritis	0.000364	0.00294	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—CRP—psoriatic arthritis	0.000322	0.0026	CbGpPWpGaD
Rifabutin—HSP90AA1—Immune System—HLA-DRB1—psoriatic arthritis	0.000308	0.00249	CbGpPWpGaD
Rifabutin—HSP90AA1—Developmental Biology—TNF—psoriatic arthritis	0.000283	0.00228	CbGpPWpGaD
Rifabutin—HSP90AA1—Disease—NOS2—psoriatic arthritis	0.000271	0.00219	CbGpPWpGaD
